Regulus Therapeutics Incorporated operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Regulus Therapeutics Incorporated with three other
companies in this sector in the United States:
Caladrius Biosciences Inc
sales of $22.49 million
of which 100%
was Cell Therapy),
Bioanalytical Systems, Inc.
Spark Therapeutics Inc
Sales increased substantially in 2015:
During the year ended December of 2015, sales at
Regulus Therapeutics Incorporated were $20.76 million.
increase of 170.7%
versus 2014, when the company's sales were $7.67 million.